Stericycle (SRCL): Medical waste firm attracts insider buying

Filed under: Newsletters, Stocks to Buy

"Stericycle (NASDAQ SRCL) is a near-monopoly in an essential but unglamorous area, making its an excellent investment in an uncertain economy," says growth stock expert Dave Dyer.

In his Dave Dyer's Newsletter, he states, "If you have something that is dangerous, contaminated, or nasty, and you want it to go away safely, you can rely on SRCL, the leader in medical waste."

"I first recommended the stock almost a year ago, but there is so much good news that I thought this would be a good time to recommend it again.

"And while the stock's 12.4% gain since last August is not spectacular, the S&P 500 is down 14.1% over the same time period -- so SRCL has outperformed the market by a wide margin.

"SRCL is North America's largest provider of medical waste services. In fact, if a major customer wants to contract with a single customer for nationwide services, SRCL is the only choice. Even if the market has not really bottomed out, this is an excellent stock to consider because its business is almost entirely immune to economic cycles.

Continue reading Stericycle (SRCL): Medical waste firm attracts insider buying

Permalink | Email this | Comments

<map name="google_ad_map_145-1284603"><area href="http://imageads.googleadservices.com/pagead/imgclick/145-1284603?pos=0" shape="rect" coords="1,2,367,28" /><area href="http://services.google.com/feedback/abg" shape="rect" coords="384,10,453,23" /></map>